Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DigitalOcean Holdings Inc (DOCN) vs 10X Genomics Inc (TXG) Price & Performance

DigitalOcean Holdings IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

DigitalOcean Holdings Inc vs 10X Genomics Inc — how do they compare? DigitalOcean Holdings Inc trades at $131.15 (market cap $14.21B), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: DigitalOcean Holdings Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, DigitalOcean Holdings Inc nearer its low. Which is the better fit depends on your goals.

DOCNTXG
Market Cap
$14.21B$7.61B
Sector
TechnologyHealth
52-Week High
$181.29$58.57
52-Week Low
$29.99$11.34
Enterprise Value
$14.97B$7.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DigitalOcean Holdings Inc

DigitalOcean (DOCN) trades at $129.73, up 4.49% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $124 and resistance at $135. Revenue growth accelerated to 29% year-over-year in Q2 2026, driven by surging AI-native cloud demand, while maintaining robust 40% adjusted EBITDA margins. Analyst consensus remains strongly positive with a $173.71 price target representing 34% upside potential.

DOCN presents compelling growth exposure to the AI infrastructure boom with accelerating revenue and strong profitability, though elevated valuation multiples (P/E 54.94) and high leverage ($1.49B debt) warrant caution. The company's strategic positioning in AI inference workloads and raised 2026 guidance support continued upside, but investors should monitor competitive pressures and execution risks in the rapidly evolving cloud market.

10X Genomics Inc

TXG trades at $58.57, up 12.57% in 24 hours, reflecting strong momentum. The stock is technically bullish with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and revenue growth, yet remains unprofitable with a negative net income margin. Recent news highlights collaborations and acquisitions expanding its genomic capabilities.

Outlook is mixed; analyst consensus is neutral with a $46 price target below current levels, indicating caution despite recent beats. Key risks include sustained losses and competitive pressures, but operational cash flow growth and strategic expansions offer potential upside for patient investors focused on long-term biotech innovation.

Returns comparison

Trailing returns across standard periods

About DigitalOcean Holdings Inc

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.

Read more on DOCN

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG